HEADER HYDROLASE/HYDROLASE INHIBITOR 24-MAY-04 1VZQ TITLE COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165 COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN HEAVY; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: SERINE PROTEASE DOMAIN, RESIDUES 364-620; COMPND 5 SYNONYM: COAGULATION FACTOR II; COMPND 6 EC: 3.4.21.5; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HIRUDIN VARIANT-2; COMPND 10 CHAIN: I; COMPND 11 FRAGMENT: C-TERMINAL PEPTIDE, RESIDUES 62-72; COMPND 12 SYNONYM: HIRUDIN IIB; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: THROMBIN LIGHT; COMPND 16 CHAIN: L; COMPND 17 FRAGMENT: RESIDUES 334-360; COMPND 18 SYNONYM: COAGULATION FACTOR II; COMPND 19 EC: 3.4.21.5; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: OVARY; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 11 ORGANISM_TAXID: 6421; SOURCE 12 OTHER_DETAILS: CHEMICALLY SYNTHESISED; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 19 EXPRESSION_SYSTEM_CELL_LINE: OVARY KEYWDS HYDROLASE, BLOOD COAGULATION, PLASMA, CALCIUM-BINDING, GLYCOPROTEIN, KEYWDS 2 SERINE PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.SHAERER,M.MORGENTHALER,P.SEILER,F.DIEDERICH,D.W.BANNER,T.TSCHOPP, AUTHOR 2 U.OBST-SANDER REVDAT 6 23-OCT-24 1VZQ 1 REMARK REVDAT 5 13-DEC-23 1VZQ 1 REMARK LINK REVDAT 4 28-JUN-17 1VZQ 1 REMARK REVDAT 3 13-JUL-11 1VZQ 1 VERSN REVDAT 2 24-FEB-09 1VZQ 1 VERSN REVDAT 1 20-JUN-05 1VZQ 0 JRNL AUTH K.SCHAERER,M.MORGENTHALER,P.SEILER,F.DIEDERICH,D.W.BANNER, JRNL AUTH 2 T.TSCHOPP,U.OBST-SANDER JRNL TITL ENANTIOMERICALLY PURE THROMBIN INHIBITORS FOR EXPLORING THE JRNL TITL 2 MOLECULAR-RECOGNITION FEATURES OF THE OXYANION HOLE JRNL REF HELV.CHIM.ACTA V. 87 2517 2004 JRNL REFN ISSN 0018-019X REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH G.RUSSO,A.GAST,E.J.SCHLAEGER,A.ANGIOLILLO,C.PIETROPAOLO REMARK 1 TITL STABLE EXPRESSION AND PURIFICATION OF A SECRETED HUMAN REMARK 1 TITL 2 RECOMBINANT PRETHROMBIN-2 AND ITS ACTIVATION TO THROMBIN REMARK 1 REF PROTEIN EXPR.PURIF. V. 10 214 1997 REMARK 1 REFN ISSN 1046-5928 REMARK 1 PMID 9226718 REMARK 1 DOI 10.1006/PREP.1997.0733 REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 43087 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2155 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.54 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.60 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2160 REMARK 3 BIN FREE R VALUE : 0.2230 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2296 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 408 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.59000 REMARK 3 B22 (A**2) : -1.82000 REMARK 3 B33 (A**2) : 1.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.31000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.16 REMARK 3 ESD FROM SIGMAA (A) : 0.09 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.11 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.260 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.890 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.890 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.670 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 50.95 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : 7165.TPX REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CHYMOTRYPSIN NUMBERING RATHER THAN REMARK 3 SEQUENTIAL SYSTEM IS USED, BASED ON THE TOPOLOGICAL ALIGNMENT REMARK 3 WITH THE STRUCTURE OF CHYMOTRYPSIN W.BODE ET AL., 1989, EMBO J.8, REMARK 3 3467-3475. THE STRUCTURE OF 1OYT.PDB WAS TAKEN AS STARTING REMARK 3 POINT FOR THE REFINEMENT. APART FROM THE INHIBITOR AND A FEW REMARK 3 WATER MOLECULES THE TWO STRUCTURES ARE THE SAME. WATER S339 HAS REMARK 3 ELECTRON DENSITY, BUT IS NOT RELIABLE ON GEOMETRIC GROUNDS. REMARK 3 OTHER WATER MOLECULES WITH B OVER 50 SHOULD NOT BE TRUSTED. THE REMARK 3 INHIBITOR AND GLU 192 HAVE GOOD DENSITY, SO THE SHORT HYDROGEN REMARK 3 BOND BETWEEN THEM IS RELIABLE REMARK 4 REMARK 4 1VZQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAY-04. REMARK 100 THE DEPOSITION ID IS D_1290020049. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.40 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMICS REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43087 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.540 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.2 REMARK 200 DATA REDUNDANCY : 7.110 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.9800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.93 REMARK 200 R MERGE FOR SHELL (I) : 0.23000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.560 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1OYT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.40 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.45000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.45000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, I, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH H2109 LIES ON A SPECIAL POSITION. REMARK 375 HOH I2010 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU I 8 REMARK 465 TYR I 9 REMARK 465 LEU I 10 REMARK 465 GLN I 11 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU I 7 CA C O CB CG CD OE1 REMARK 470 GLU I 7 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O24 SHY H 1256 O HOH H 2334 2.10 REMARK 500 OE2 GLU L 13 O HOH L 2020 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU H 41 CA - CB - CG ANGL. DEV. = 15.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS H 42 174.37 178.24 REMARK 500 TYR H 60A 87.21 -152.99 REMARK 500 ASN H 60G 77.68 -158.87 REMARK 500 HIS H 71 -57.30 -134.21 REMARK 500 ILE H 79 -59.79 -126.80 REMARK 500 ASN H 98 13.99 -158.17 REMARK 500 PRO I 6 -38.33 -38.71 REMARK 500 PHE L 7 -89.31 -131.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH H2018 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH H2023 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH H2028 DISTANCE = 6.47 ANGSTROMS REMARK 525 HOH H2039 DISTANCE = 6.37 ANGSTROMS REMARK 525 HOH I2016 DISTANCE = 7.11 ANGSTROMS REMARK 525 HOH L2043 DISTANCE = 5.98 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA H1258 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LYS H 169 O REMARK 620 2 THR H 172 O 72.0 REMARK 620 3 PHE H 204A O 90.9 91.3 REMARK 620 4 HOH H2232 O 80.4 151.4 81.6 REMARK 620 5 HOH H2233 O 119.0 130.9 132.6 69.6 REMARK 620 6 HOH H2246 O 62.6 70.9 151.3 103.1 74.0 REMARK 620 7 HOH H2287 O 160.1 90.0 80.9 115.9 79.1 120.2 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA H1257 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ARG H 221A O REMARK 620 2 LYS H 224 O 95.9 REMARK 620 3 HOH H2260 O 159.2 68.5 REMARK 620 4 HOH H2305 O 109.6 153.6 85.1 REMARK 620 5 HOH H2312 O 103.6 85.0 89.1 95.4 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SHY H 1256 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA H 1257 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA H 1258 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF HIRUDIN VARIANT-2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A2C RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN INHIBITED BY AERUGINOSIN298-A FROM A BLUE- REMARK 900 GREEN ALGA REMARK 900 RELATED ID: 1A3B RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE REMARK 900 INHIBITOR BOROLOG1 REMARK 900 RELATED ID: 1A3E RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE REMARK 900 INHIBITOR BOROLOG2 REMARK 900 RELATED ID: 1A46 RELATED DB: PDB REMARK 900 THROMBIN COMPLEXED WITH HIRUGEN AND A BETA- STRAND MIMETIC INHIBITOR REMARK 900 RELATED ID: 1A4W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE- CONTAINING INHIBITORS: REMARK 900 PROBES OF THE S1' BINDING SITE REMARK 900 RELATED ID: 1A5G RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC REMARK 900 INHIBITOR AND HIRUGEN REMARK 900 RELATED ID: 1A61 RELATED DB: PDB REMARK 900 THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR REMARK 900 RELATED ID: 1ABI RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRULOG 3 REMARK 900 RELATED ID: 1ABJ RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE (PPACK) REMARK 900 WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1AD8 RELATED DB: PDB REMARK 900 COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY REMARK 900 RELATED ID: 1AE8 RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D- PHE-PRO-AZALYS-ONP REMARK 900 RELATED ID: 1AFE RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO- AZALYS-ONP REMARK 900 RELATED ID: 1AHT RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: ALPHA-THROMBIN; CHAIN: L, H; EC: 3.4.21.5; MOL_ REMARK 900 ID: 2; MOLECULE: HIRUGEN; CHAIN: I; HETEROGEN: P- AMIDINO-PHENYL- REMARK 900 PYRUVATE REMARK 900 RELATED ID: 1AI8 RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE INHIBITOR REMARK 900 HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA- PRO-BOROMPG REMARK 900 RELATED ID: 1AIX RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN REMARK 900 AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROVAL REMARK 900 RELATED ID: 1AWF RELATED DB: PDB REMARK 900 NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT REMARK 900 RELATED ID: 1AWH RELATED DB: PDB REMARK 900 NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT REMARK 900 RELATED ID: 1AY6 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED REMARK 900 MACROCYCLIC TRIPEPTIDE MOTIF REMARK 900 RELATED ID: 1B5G RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC REMARK 900 INHIBITOR AND HIRUGEN REMARK 900 RELATED ID: 1B7X RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN ALPHA-THROMBIN Y225I MUTANT BOUND TO D- PHE-PRO- REMARK 900 ARG- CHLOROMETHYLKETONE REMARK 900 RELATED ID: 1BA8 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES REMARK 900 RELATED ID: 1BB0 RELATED DB: PDB REMARK 900 THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES REMARK 900 RELATED ID: 1BCU RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN REMARK 900 RELATED ID: 1BHX RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE REMARK 900 INHIBITOR SDZ 229-357 REMARK 900 RELATED ID: 1BMM RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R, R)]-4- REMARK 900 [(AMINOIMINOMETHYL)AMINO]-N-[[1-[3- HYDROXY-2-[(2- REMARK 900 NAPHTHALENYLSULFONYL)AMINO]-1- OXOPROPYL]-2-PYRROLIDINYL] METHYL] REMARK 900 BUTANAMIDE (BMS-186282) REMARK 900 RELATED ID: 1BMN RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R, R)]-1- (AMINOIMINOMETHYL) REMARK 900 -N-[[1-[N-[(2- NAPHTHALENYLSULFONYL)-L- SERYL]-PYRROLIDINYL] METHYL] REMARK 900 -3-PIPERIDENECARBOXAMIDE (BMS- 189090) REMARK 900 RELATED ID: 1BTH RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1C1U RELATED DB: PDB REMARK 900 RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE REMARK 900 PROTEASES REMARK 900 RELATED ID: 1C1V RELATED DB: PDB REMARK 900 RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE REMARK 900 PROTEASES REMARK 900 RELATED ID: 1C1W RELATED DB: PDB REMARK 900 RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE REMARK 900 PROTEASES REMARK 900 RELATED ID: 1C4U RELATED DB: PDB REMARK 900 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL REMARK 900 MOIETIES. REMARK 900 RELATED ID: 1C4V RELATED DB: PDB REMARK 900 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL REMARK 900 MOIETIES. REMARK 900 RELATED ID: 1C4Y RELATED DB: PDB REMARK 900 SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS REMARK 900 RELATED ID: 1C5L RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1C5N RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1C5O RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1CA8 RELATED DB: PDB REMARK 900 THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES REMARK 900 RELATED ID: 1D3D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH REMARK 900 BENZOTHIOPHENE INHIBITOR 4 REMARK 900 RELATED ID: 1D3P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 3 REMARK 900 RELATED ID: 1D3Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 2 REMARK 900 RELATED ID: 1D3T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 1 REMARK 900 RELATED ID: 1D4P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5- REMARK 900 AMIDINOINDOLE-4- BENZYLPIPERIDINE INHIBITOR REMARK 900 RELATED ID: 1D6W RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- ELECTROPHILIC REMARK 900 INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1 REMARK 900 RELATED ID: 1D9I RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- ELECTOPHILIC REMARK 900 INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1 REMARK 900 RELATED ID: 1DE7 RELATED DB: PDB REMARK 900 INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA- THROMBIN: REMARK 900 CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX REMARK 900 RELATED ID: 1DIT RELATED DB: PDB REMARK 900 COMPLEX OF A DIVALENT INHIBITOR WITH THROMBIN REMARK 900 RELATED ID: 1DM4 RELATED DB: PDB REMARK 900 SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A REMARK 900 (7-16) REMARK 900 RELATED ID: 1DOJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN* RWJ-51438 COMPLEXAT 1.7 A REMARK 900 RELATED ID: 1DWB RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 REMARK 900 - 65) AND BENZAMIDINE REMARK 900 RELATED ID: 1DWC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 REMARK 900 - 65) AND MD-805 (ARGATROBAN) REMARK 900 RELATED ID: 1DWD RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 REMARK 900 - 65) AND NAPAP REMARK 900 RELATED ID: 1DWE RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 REMARK 900 - 65) AND D-PHE- PRO-ARG-CHLOROMETHYLKETONE (PPACK) WITH REMARK 900 CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1DX5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE THROMBIN- THROMBOMODULIN COMPLEX REMARK 900 RELATED ID: 1E0F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN ALPHA- THROMBIN-HAEMADIN COMPLEX: AN REMARK 900 EXOSITE II- BINDING INHIBITOR REMARK 900 RELATED ID: 1EB1 RELATED DB: PDB REMARK 900 COMPLEX STRUCTURE OF HUMAN THROMBIN WITH N- METHYL-ARGININE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1EOJ RELATED DB: PDB REMARK 900 DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND REMARK 900 THEIR CRYSTAL STRUCTURES REMARK 900 RELATED ID: 1EOL RELATED DB: PDB REMARK 900 DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND REMARK 900 THEIR CRYSTAL STRUCTURES REMARK 900 RELATED ID: 1FPC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN AND REMARK 900 ACTIVE SITE INHIBITOR DANSYLARGININE N-(3-ETHYL -1,5-PENTANEDIYL) REMARK 900 AMIDE (DAPA) REMARK 900 RELATED ID: 1FPH RELATED DB: PDB REMARK 900 ALPHA-THROMBIN TERNARY COMPLEX WITH HIRUDIN AND FIBRINOPEPTIDE A REMARK 900 RELATED ID: 1G30 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1G32 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1G37 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITHBCH -10556 REMARK 900 AND EXOSITE-DIRECTED PEPTIDE REMARK 900 RELATED ID: 1GHV RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GHW RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GHX RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GHY RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GJ4 RELATED DB: PDB REMARK 900 SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA,SER190/ALA190 REMARK 900 PROTEASE, STRUCTURE-BASED DRUG DESIGN REMARK 900 RELATED ID: 1GJ5 RELATED DB: PDB REMARK 900 SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA,SER190/ALA190 REMARK 900 PROTEASE, STRUCTURE-BASED DRUG DESIGN REMARK 900 RELATED ID: 1H8D RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF THE HUMAN ALPHA- THROMBIN COMPLEX WITH A REMARK 900 TRIPEPTIDE PHOSPHONATE INHIBITOR. REMARK 900 RELATED ID: 1H8I RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN ALPHA- THROMBIN WITH A TRIPEPTIDE REMARK 900 PHOSPHONATE INHIBITOR. REMARK 900 RELATED ID: 1HAG RELATED DB: PDB REMARK 900 PRETHROMBIN2 COMPLEXED WITH HIRUGEN (N- ACETYLHIRUDIN 53 - 64 WITH REMARK 900 SULFATO-TYR 63) REMARK 900 RELATED ID: 1HAH RELATED DB: PDB REMARK 900 ALPHA THROMBIN COMPLEXED WITH HIRUGEN (N- ACETYLHIRUDIN 53 - 64 REMARK 900 WITH SULFATO-TYR 63) REMARK 900 RELATED ID: 1HAI RELATED DB: PDB REMARK 900 ALPHA THROMBIN COMPLEXED WITH D-PHE-PRO- ARG- CHLOROMETHYLKETONE REMARK 900 (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1HAO RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE REMARK 900 GGTTGGTGTGGTTGG (BASED ON NMR MODEL OF DEOXYRIBONUCLEIC ACID) REMARK 900 RELATED ID: 1HAP RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE REMARK 900 GGTTGGTGTGGTTGG (BASED ON X-RAY MODEL OF DEOXYRIBONUCLEIC ACID) REMARK 900 RELATED ID: 1HBT RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL REMARK 900 KETONE CONTAINING BIVALENT INHIBITOR REMARK 900 RELATED ID: 1HDT RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: ALPHA-THROMBIN; CHAIN: L, H; EC: 3.4.21.5; MOL_ REMARK 900 ID: 2; MOLECULE: HIRUGEN PEPTIDE; CHAIN: P; ENGINEERED: YES; MOL_ID: REMARK 900 3; MOLECULE: N-[N -[N-[4- (AMINOIMINOMETHYL)AMINO]-1-OXOBUTYL]- L - REMARK 900 PHENYLALANYL]-L- ALLO-THREONYL-L- PHENYLALANINE, METHYL ESTER (BMS- REMARK 900 183507); CHAIN: I; ENGINEERED: YES REMARK 900 RELATED ID: 1HGT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUGEN REMARK 900 RELATED ID: 1HLT RELATED DB: PDB REMARK 900 ALPHA THROMBIN COMPLEXED WITH THROMBOMODULIN (NONDECAPEPTIDE) AND D- REMARK 900 PHE-PRO-ARG- CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REMARK 900 REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1HUT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH DEOXYRIBONUCLEIC ACID (5'- REMARK 900 D(GPGPTPTPGPGPTPGPTPGPGPTPTPGPG)-3') AND D-PHE-PRO-ARG- REMARK 900 CHLOROMETHYLKETONE (PPACK ) WITH CHLOROMETHYLKETONE REPLACED BY A REMARK 900 METHYLENE GROUP REMARK 900 RELATED ID: 1HXE RELATED DB: PDB REMARK 900 SERINE PROTEASE REMARK 900 RELATED ID: 1HXF RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT REMARK 900 RELATED ID: 1IHS RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUTONIN-2 REMARK 900 RELATED ID: 1IHT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUTONIN-6 REMARK 900 RELATED ID: 1JMO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II -S195A THROMBINCOMPLEX REMARK 900 RELATED ID: 1JOU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NATIVE S195A THROMBIN WITH ANUNOCCUPIED ACTIVE REMARK 900 SITE REMARK 900 RELATED ID: 1JWT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH A NOVELBICYCLIC REMARK 900 LACTAM INHIBITOR REMARK 900 RELATED ID: 1K21 RELATED DB: PDB REMARK 900 HUMAN THROMBIN-INHIBITOR COMPLEX REMARK 900 RELATED ID: 1K22 RELATED DB: PDB REMARK 900 HUMAN THROMBIN-INHIBITOR COMPLEX REMARK 900 RELATED ID: 1KTS RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1KTT RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1LHC RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BOROARG- OH REMARK 900 RELATED ID: 1LHD RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BOROLYS- OH REMARK 900 RELATED ID: 1LHE RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BORO-N- BUTYL- REMARK 900 AMIDINO-GLYCINE-OH REMARK 900 RELATED ID: 1LHF RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BORO- HOMOLYS-OH REMARK 900 RELATED ID: 1LHG RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO- BOROORNITHINE-OH REMARK 900 RELATED ID: 1MH0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN REMARK 900 RELATED ID: 1MU6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622 REMARK 900 RELATED ID: 1MU8 RELATED DB: PDB REMARK 900 THROMBIN-HIRUGEN_L-378,650 REMARK 900 RELATED ID: 1MUE RELATED DB: PDB REMARK 900 THROMBIN-HIRUGEN-L405,426 REMARK 900 RELATED ID: 1NM6 RELATED DB: PDB REMARK 900 THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR AT1.8A REMARK 900 RELATED ID: 1NO9 RELATED DB: PDB REMARK 900 DESIGN OF WEAKLY BASIC THROMBIN INHIBITORS INCORPORATINGNOVEL P1 REMARK 900 BINDING FUNCTIONS: MOLECULAR AND X- RAYCRYSTALLOGRAPHIC STUDIES. REMARK 900 RELATED ID: 1NRN RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 NRS REMARK 900 RELATED ID: 1NRO RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 NRP REMARK 900 RELATED ID: 1NRP RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 NR'S REMARK 900 RELATED ID: 1NRQ RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 D-FPR'S REMARK 900 RELATED ID: 1NRR RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 XA AND D-PHE-PRO- ARG CHLOROMETHYLKETONE (PPACK) WITH REMARK 900 CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1NRS RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 NRP (CLEAVED, FIRST FOUR RESIDUES ONLY) AND HIRUGEN REMARK 900 RELATED ID: 1NT1 RELATED DB: PDB REMARK 900 THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR REMARK 900 RELATED ID: 1NU7 RELATED DB: PDB REMARK 900 STAPHYLOCOAGULASE-THROMBIN COMPLEX REMARK 900 RELATED ID: 1NU9 RELATED DB: PDB REMARK 900 STAPHYLOCOAGULASE-PRETHROMBIN-2 COMPLEX REMARK 900 RELATED ID: 1NY2 RELATED DB: PDB REMARK 900 HUMAN ALPHA THROMBIN INHIBITED BY RPPGF AND HIRUGEN REMARK 900 RELATED ID: 1NZQ RELATED DB: PDB REMARK 900 D-PHE-PRO-ARG-TYPE THROMBIN INHIBITOR REMARK 900 RELATED ID: 1O0D RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH A D-PHE-PRO -ARG- TYPEINHIBITOR AND A REMARK 900 C-TERMINAL HIRUDIN DERIVED EXO- SITEINHIBITOR REMARK 900 RELATED ID: 1O2G RELATED DB: PDB REMARK 900 ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING REMARK 900 OF ACTIVE SITE- DIRECTED SERINE PROTEASE INHIBITORS REMARK 900 RELATED ID: 1OOK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- ALPHA REMARK 900 AND HUMAN ALPHA- THROMBIN REMARK 900 RELATED ID: 1OYT RELATED DB: PDB REMARK 900 COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNEDFLUORINATED REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1P8V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- ALPHA REMARK 900 AND ALPHA-THROMBIN AT 2.6A REMARK 900 RELATED ID: 1PPB RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE (PPACK) REMARK 900 WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1QBV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE- MIMETIC REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1QHR RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QJ1 RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QJ6 RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QJ7 RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QUR RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN IN COMPLEX WITH BIVALENT, BENZAMIDINE- BASED REMARK 900 SYNTHETIC INHIBITOR REMARK 900 RELATED ID: 1QVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THROMBIN AND THECENTRAL "E" REMARK 900 REGION OF FIBRIN REMARK 900 RELATED ID: 1RD3 RELATED DB: PDB REMARK 900 2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K REMARK 900 RELATED ID: 1SFQ RELATED DB: PDB REMARK 900 FAST FORM OF THROMBIN MUTANT R(77A)A BOUND TO PPACK REMARK 900 RELATED ID: 1SG8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PROCOAGULANT FAST FORM OF THROMBIN REMARK 900 RELATED ID: 1SGI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN REMARK 900 RELATED ID: 1SHH RELATED DB: PDB REMARK 900 SLOW FORM OF THROMBIN BOUND WITH PPACK REMARK 900 RELATED ID: 1TA2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 1 REMARK 900 RELATED ID: 1TA6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B REMARK 900 RELATED ID: 1TBZ RELATED DB: PDB REMARK 900 HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N- [5- REMARK 900 (AMINOIMINOMETHYL)AMINO]- 1-{{BENZOTHIAZOLYL)CARBONYL] BUTYL]-L- REMARK 900 PROLINAMIDE TRIFLUROACETATE AND EXOSITE-HIRUGEN REMARK 900 RELATED ID: 1THP RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D- PHE-PRO- REMARK 900 ARG- CHLOROMETHYLKETONE REMARK 900 RELATED ID: 1THR RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRULLIN REMARK 900 RELATED ID: 1THS RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH MDL-28050 REMARK 900 RELATED ID: 1TMB RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUGEN AND CYCLOTHEONAMIDE A REMARK 900 RELATED ID: 1TMT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH CGP 50,856 (D-PHE-PRO-ARG-PRO -GLY- REMARK 900 GLY-GLY-GLY FOLLOWED BY RESIDUES 53 - 65 OF HIRUDIN, CLEAVED AFTER REMARK 900 ARG I 3) REMARK 900 RELATED ID: 1TMU RELATED DB: PDB REMARK 900 ALPHA-THROMBIN TERNARY COMPLEX WITH HIRUDIN (C-TERMINAL FRAGMENT, REMARK 900 RESIDUES 55 - 65) AND PPACK (D-PHE-PRO-ARG- CHLOROMETHYLKETONE) REMARK 900 RELATED ID: 1TOM RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH HIRUGEN REMARK 900 RELATED ID: 1UMA RELATED DB: PDB REMARK 900 ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA- (N,N- DIMETHYLCARBAMOYL) REMARK 900 -ALPHA-AZALYSINE REMARK 900 RELATED ID: 1UVS RELATED DB: PDB REMARK 900 BOVINE THROMBIN--BM51.1011 COMPLEX REMARK 900 RELATED ID: 1VR1 RELATED DB: PDB REMARK 900 SPECIFITY FOR PLASMINOGEN ACTIVATOR INHIBITOR-1 REMARK 900 RELATED ID: 1VZQ RELATED DB: PDB REMARK 900 COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165 REMARK 900 RELATED ID: 2HGT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRULOG I (CLEAVED BETWEEN ARG 3 AND REMARK 900 PRO 4) REMARK 900 RELATED ID: 2HNT RELATED DB: PDB REMARK 900 GAMMA-THROMBIN REMARK 900 RELATED ID: 2HPP RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG - CHLOROMETHYLKETONE REMARK 900 (PPACK) CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP AND BOVINE REMARK 900 PROTHROMBIN FRAGMENT 2 REMARK 900 RELATED ID: 2HPQ RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG - CHLOROMETHYLKETONE REMARK 900 (PPACK) CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP AND HUMAN REMARK 900 PROTHROMBIN FRAGMENT 2 REMARK 900 RELATED ID: 2THF RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D- PHE-PRO- REMARK 900 ARG- CHLOROMETHYLKETONE REMARK 900 RELATED ID: 3HAT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND FPAM (FIBRINOPEPTIDE A REMARK 900 MIMIC) REMARK 900 RELATED ID: 3HTC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH RECOMBINANT HIRUDIN (VARIANT 2, LYS 47) REMARK 900 RELATED ID: 4HTC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH RECOMBINANT HIRUDIN (VARIANT 2, LYS 47) REMARK 900 RELATED ID: 4THN RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF ALPHA-THROMBIN- HIRUNORM IV COMPLEX REMARK 900 REVEALS A NOVEL SPECIFICITY SITE RECOGNITION MODE. REMARK 900 RELATED ID: 5GDS RELATED DB: PDB REMARK 900 HIRUNORMS ARE TRUE HIRUDIN MIMETICS. THE CRYSTAL STRUCTURE OF HUMAN REMARK 900 ALPHA-THROMBIN: HIRUNORM V COMPLEX REMARK 900 RELATED ID: 7KME RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2711. REMARK 900 RELATED ID: 8KME RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2770. DBREF 1VZQ H 16 255 UNP P00734 THRB_HUMAN 364 620 DBREF 1VZQ I 1 11 UNP P09945 ITH3_HIRME 62 72 DBREF 1VZQ L 1 14K UNP P00734 THRB_HUMAN 334 360 SEQRES 1 H 250 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 H 250 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 H 250 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 H 250 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 H 250 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 H 250 HIS SER ARG THR ALA TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 H 250 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 H 250 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 H 250 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 H 250 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 H 250 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 H 250 LEU LYS GLU THR GLY GLN PRO SER VAL LEU GLN VAL VAL SEQRES 13 H 250 ASN LEU PRO ILE VAL GLU ARG PRO VAL CYS LYS ASP SER SEQRES 14 H 250 THR ARG ILE ARG ILE THR ASP ASN MET PHE CYS ALA GLY SEQRES 15 H 250 TYR LYS PRO ASP GLU GLY LYS ARG GLY ASP ALA CYS GLU SEQRES 16 H 250 GLY ASP SER GLY GLY PRO PHE VAL MET LYS SER PRO PHE SEQRES 17 H 250 ASN ASN ARG TRP TYR GLN MET GLY ILE VAL SER TRP GLY SEQRES 18 H 250 GLU GLY CYS ASP ARG ASP GLY LYS TYR GLY PHE TYR THR SEQRES 19 H 250 HIS VAL PHE ARG LEU LYS LYS TRP ILE GLN LYS VAL ILE SEQRES 20 H 250 ASP GLN PHE SEQRES 1 I 11 ASP PHE GLU GLU ILE PRO GLU GLU TYR LEU GLN SEQRES 1 L 27 ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SER SEQRES 2 L 27 LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER TYR SEQRES 3 L 27 ILE HET SHY H1256 33 HET NA H1257 1 HET CA H1258 1 HETNAM SHY 4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)- HETNAM 2 SHY 7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN- HETNAM 3 SHY 4-YL]BENZENECARBOXIMIDAMIDE HETNAM NA SODIUM ION HETNAM CA CALCIUM ION FORMUL 4 SHY C24 H24 N4 O5 FORMUL 5 NA NA 1+ FORMUL 6 CA CA 2+ FORMUL 7 HOH *408(H2 O) HELIX 1 1 ALA H 55 CYS H 58 5 4 HELIX 2 2 PRO H 60B ASP H 60E 5 4 HELIX 3 3 THR H 60I ASN H 62 5 3 HELIX 4 4 ASP H 125 LEU H 130 1 9 HELIX 5 5 GLU H 164 SER H 171 1 8 HELIX 6 6 LYS H 185 GLY H 186C 5 5 HELIX 7 7 LEU H 234 PHE H 255 1 12 HELIX 8 8 PHE L 7 SER L 11 5 5 HELIX 9 9 THR L 14B TYR L 14J 1 9 SHEET 1 HA 7 SER H 20 ASP H 21 0 SHEET 2 HA 7 GLN H 156 PRO H 161 -1 O VAL H 157 N SER H 20 SHEET 3 HA 7 LYS H 135 GLY H 140 -1 O GLY H 136 N LEU H 160 SHEET 4 HA 7 PRO H 198 LYS H 202 -1 O PRO H 198 N THR H 139 SHEET 5 HA 7 TRP H 207 TRP H 215 -1 O TYR H 208 N MET H 201 SHEET 6 HA 7 GLY H 226 HIS H 230 -1 O PHE H 227 N SER H 214 SHEET 7 HA 7 MET H 180 ALA H 183 -1 O PHE H 181 N TYR H 228 SHEET 1 HB 7 LYS H 81 SER H 83 0 SHEET 2 HB 7 LEU H 64 ILE H 68 -1 O VAL H 66 N SER H 83 SHEET 3 HB 7 GLN H 30 ARG H 35 -1 O MET H 32 N ARG H 67 SHEET 4 HB 7 GLU H 39 LEU H 46 -1 O GLU H 39 N ARG H 35 SHEET 5 HB 7 TRP H 51 THR H 54 -1 O LEU H 53 N SER H 45 SHEET 6 HB 7 ALA H 104 LEU H 108 -1 O ALA H 104 N THR H 54 SHEET 7 HB 7 LEU H 85 ILE H 90 -1 N GLU H 86 O LYS H 107 SHEET 1 HC 2 LEU H 60 TYR H 60A 0 SHEET 2 HC 2 LYS H 60F ASN H 60G-1 O LYS H 60F N TYR H 60A SSBOND 1 CYS H 42 CYS H 58 1555 1555 2.02 SSBOND 2 CYS H 122 CYS L 1 1555 1555 2.05 SSBOND 3 CYS H 168 CYS H 182 1555 1555 2.02 SSBOND 4 CYS H 191 CYS H 220 1555 1555 2.07 LINK O LYS H 169 CA CA H1258 1555 1555 2.71 LINK O THR H 172 CA CA H1258 1555 1555 2.65 LINK O PHE H 204A CA CA H1258 4546 1555 2.66 LINK O ARG H 221A NA NA H1257 1555 1555 2.26 LINK O LYS H 224 NA NA H1257 1555 1555 2.38 LINK NA NA H1257 O HOH H2260 1555 1555 2.53 LINK NA NA H1257 O HOH H2305 1555 1555 2.44 LINK NA NA H1257 O HOH H2312 1555 1555 2.15 LINK CA CA H1258 O HOH H2232 1555 1555 2.66 LINK CA CA H1258 O HOH H2233 1555 1555 2.98 LINK CA CA H1258 O HOH H2246 1555 1555 2.93 LINK CA CA H1258 O HOH H2287 1555 4546 2.59 CISPEP 1 SER H 36A PRO H 37 0 -0.52 SITE 1 AC1 19 HIS H 57 TYR H 60A TRP H 60D TRP H 96 SITE 2 AC1 19 GLU H 97A ASN H 98 LEU H 99 ASP H 189 SITE 3 AC1 19 ALA H 190 GLU H 192 SER H 214 TRP H 215 SITE 4 AC1 19 GLY H 216 GLY H 219 GLY H 226 HOH H2149 SITE 5 AC1 19 HOH H2314 HOH H2333 HOH H2334 SITE 1 AC2 6 ARG H 221A LYS H 224 HOH H2260 HOH H2261 SITE 2 AC2 6 HOH H2305 HOH H2312 SITE 1 AC3 7 LYS H 169 THR H 172 PHE H 204A HOH H2232 SITE 2 AC3 7 HOH H2233 HOH H2246 HOH H2287 SITE 1 AC4 17 PHE H 34 GLN H 38 ARG H 73 THR H 74 SITE 2 AC4 17 ALA H 75 TYR H 76 GLN H 151 HOH H2099 SITE 3 AC4 17 HOH H2103 HOH H2108 HOH I2001 HOH I2002 SITE 4 AC4 17 HOH I2003 HOH I2004 HOH I2005 HOH I2006 SITE 5 AC4 17 HOH I2007 CRYST1 70.900 71.400 72.400 90.00 100.40 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014104 0.000000 0.002589 0.00000 SCALE2 0.000000 0.014006 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014043 0.00000